this article attempts to critically review these studies under seven different sections : furosemide pharmacokinetics in normal volunteers , furosemide pharmacokinetics in patients with decreased renal function , furosemide pharmacokinetics in patients with congestive heart failure , furosemide metabolism and assay methods , furosemide bioavailability , dose-response relationships , and the role of inhibitors and mediators on furosemide effects .
C0018802
congestive heart failure
C0016860
furosemide